Andrea rappagliosi gsk. Rappagliosi joined the EuropaBio board .

Andrea rappagliosi gsk. He is leading the Government Afairs, Market Access, Communication and Patients Advocacy engagement for the company. Although biotechnology has produced health benefits, biopharmaceutical Learn about the role of Andrea Rappagliosi, Senior Vice President Public Affairs EMEA, Canada and LATAM at Edwards Li Full bio on The Official Board. Andrea began his professional career in the Italian Senate. ANDREA RAPPAGLIOSI BOARD MEMBER (Switzerland) Senior Vice-President Public Affairs EMEACLA at . Jan 16, 2013 · Vice president of Market Access, Health Policy & Medical Affairs at Sanofi Pasteur MSD Andrea Rappagliosi has been appointed president of Vaccines Europe. DOINA CARMEN MAZILU BOARD MEMBER (Romania) The Order of Nurses, Midwives and Medical Assistants in Romania (OAMGMAMR) Mr. He is leading the Government Affairs, Market Access, Communication and Patients Advocacy engagement for the company. He succeeds Steen Riisgaard, President and CEO, Novozymes A/S, who has completed his term, but will stay on as a board member. Andrea is a skilled professional who by his example, has inspired me with his ability to generate quality high level governmental and HTA community relations. JOSE LUIS GOMEZ BOARD MEMBER (Spain) VP Public Policy and Advocacy Europe, Middle East and Africa, Becton Dickinson (BD) Mr. Andrea Rappagliosi Senior Vice-President of Public Affairs for EMEA, Canada and LATAM at Edwards Lifesciences A member of the regional executive leadership team at Edwards Lifesciences, Andrea Rappagliosi leads the company’s government affairs, market access, communication and patients advocacy engagement. Vaccines Europe is the group representing vaccine manufacturers within the European Federation of Pharmaceutical Industries and Associations (EFPIA), the professional association of the European pharmaceutical industry. May 5, 2025 · Andrea received a law degree from the University of Rome, La Sapienza. Mrs. May 24, 2022 · Andrea is currently Senior Vice-President Public Affairs EMEA, Canada and LATAM at Edwards Lifesciences based in Switzerland and member of the regional Executive Leadership Team. Before joining Edwards Lifesciences, Andrea worked at Baxter Healthcare, Serono, GSK and Sanofi in different European and International positions in the public affairs and market access policy area. Jun 24, 2009 · EuropaBio, the European Association for Bioindustries, has elected Andrea Rappagliosi, Vice President European Government Affairs, GlaxoSmithKline, to chair the association over the next two years at its Annual General Assembly. Its members include vaccine manufacturers such as Sanofi Pasteur MSD, AstraZeneca, Sanofi Pasteur, Novartis, GlaxoSmithKline Biologicals, Pfizer, Crucell, Abbott, Baxter and MSD. Recently he worked in the Sanofi group as VP Public Affairs Europe and before as VP, Market Access, Health Policy and Medical Affairs at Sanofi Pasteur MSD. Rappagliosi joined the EuropaBio board Sanofi Pasteur MSD’s Andrea Rappagliosi also is president of Vaccines Europe, an industry group that just launched an initiative to promote the preventive health value of vaccines. Immunization schedules vary by country, requiring different doses and frequency of jabs. Apr 21, 2016 · A major hurdle the industry faces is meeting the fragmented demand across Europe’s markets, according to Andrea Rappagliosi, president of Vaccines Europe, an industry group. Biopharmaceuticals and innovative therapeutic solutions offer treatments that are increasingly tailored to patient needs. I would heartily recommend Andrea Andrea is currently Senior Vice-President Public Afairs EMEA, Canada and LATAM at Edwards Lifesciences and member of the regional Executive Leadership Team. ev1mdppv nz fk17rj zu756g ekx sb6cg hkqi zqf 0sv o3c